Genome editing using  CRISPR/Cas9 is a promising possibility for correcting diseases due to genetic mutations (see HERE ), such as Duchenne muscular dystrophy – lethal degeneration of cardiac and skeletal muscle caused by different genetic mutations (see more HERE), which causes degeneration of the cardiac and skeletal muscles as a result of more than 3,000 mutations in an X-linked gene.

Duchenne new possible treatment

A technique has now been proposed using CRISPR/Cas9 that might allow correction of several genetic mutations in the cardiac muscle after modifying its genome, enabling the genetic alterations in this serious disease to be eliminated. One more step in the use of gene editing and CRISPR/Cas9 in clinical medicine.

Photo Medindia


Subscribe to our newsletter:

We don’t spam! Read our privacy policy for more info.